Publicaciones
- 
                        Carton, C, Evans, DG, Blanco, I, Friedrich, RE, Ferner, RE, Farschtschi, S, Salvador-Hernandez H, Azizi, AA, Mautner, V, Rohl, C, Peltonen, S, Stivaros, S, Legius, E and Oostenbrink, R. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1EClinicalMedicine . 56: . Nº de citas: 64 
- 
                        Parada-Avendaño I, Salvador-Hernandez H, García RG, Martorell-Sampol L, García-Fontecha CG, Torner-Rubies F and Pérez-López LM. Lateralized overgrowth as a guiding sign of abdominal neoplasms for pediatric orthopedic surgeonsJoint Diseases and Related Surgery . 34(1): 3-8. Nº de citas: 2 
- 
                        Catasús N, Rosas I, Bonache S, Negro A, Torres-Martin M, Plana-Pla A, Salvador-Hernandez H, Serra E, Blanco I and Castellanos E. Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitroMOLECULAR THERAPY NUCLEIC ACIDS . 30: 493-505. Nº de citas: 5 
- 
                        Hendricks LAJ, Hoogerbrugge N, Venselaar H, Aretz S, Spier I, Legius E, Brems H, de Putter R, Claes KBM, Evans DG, Woodward ER, Genuardi M, Brugnoletti F, van Ierland Y, Dijke K, Tham E, Tesi B, Schuurs-Hoeijmakers JHM, Branchaud M, Salvador-Hernandez H, Jahn A, Schnaiter S, Anastasiadou VC, Brunet J, Oliveira C, Roht L, Blatnik A, Irmejs A, Mensenkamp AR and Vos JR. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohortEUROPEAN JOURNAL OF MEDICAL GENETICS . 65(12): 104632-104632. Nº de citas: 20 
- 
                        Guerrini-Rousseau L, Smith MJ, Kratz CP, Doergeloh B, Hirsch S, Hopman SMJ, Jorgensen M, Kuhlen M, Michaeli O, Milde T, Ridola V, Russo A, Salvador-Hernandez H, Waespe N, Claret B, Brugieres L and Evans DG. Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).FAMILIAL CANCER . 20(4): 317-325. Nº de citas: 29 
- 
                        Magallón-Lorenz M, Fernández-Rodríguez J, Terribas E, Creus-Batchiller E, Romagosa C, Estival A, Perez Sidelnikova D, Salvador-Hernandez H, Villanueva A, Blanco I, Carrió M, Lázaro C, Serra E and Gel B. Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation.HUMAN GENETICS . 140(8): 1241-1252. Nº de citas: 15 
- 
                        Alamar AM, Candela-Cantó SA, Flor-Goikoetxea A, Salvador-Hernandez H, Martinez-Monseny T, Muchart-Lopez J and Hinojosa J. Megalencephaly-capillary malformation syndrome and associated hydrocephalus: treatment options and revision of the literatureCHILDS NERVOUS SYSTEM . 37(8): 2441-2449. Nº de citas: 2 
- 
                        Bao R, Ng A, Sasaki M, Esai Selvan M, Katti A, Lee H, Huang L, Skol AD, Lavarino C, Salvador-Hernandez H, Klein RJ, Gümüs ZH, Mora J and Onel K. Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer SusceptibilityCANCER PREVENTION RESEARCH . 14(4): 441-453. Nº de citas: 2 
- 
                        Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C. Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndromeHEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1. Nº de citas: 2 
- 
                        Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS. Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in childrenPEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de citas: 8 
